Grown Rogue International (GRUSF) Non Operating Income (2011 - 2026)
Grown Rogue International (GRUSF) recorded quarterly Non Operating Income of $165268.0 in Q1 2026, up 100.0% quarter-over-quarter from -$7349.3 billion in Q4 2025, and down 92.07% on a YoY basis from $2.1 million in Q1 2025.
Grown Rogue International (GRUSF) Non Operating Income (2011 - 2026) Analysis & Trends
Grown Rogue International's Non Operating Income history runs 6 years deep, the most recent figure standing at $165268.0 for Q1 2026.
- In Q1 2026, Non Operating Income fell 92.07% year-over-year to $165268.0; the TTM figure through Mar 2026 stood at -$4803.7 billion (down 140.47% YoY), while the FY2025 annual figure was $932730.0, up 107.66% from the prior year.
- Non Operating Income was $165268.0 for Q1 2026 at Grown Rogue International, up from -$7349.3 billion in the prior quarter.
- In the past five years, Non Operating Income ranged from a high of $13256.2 billion in Q4 2024 to a low of -$7349.3 billion in Q4 2025.
- Historically, Non Operating Income has averaged $642.5 billion across 4 years, with a median of $165268.0 in 2026.
- The sharpest annual moves came in 2024 and 2025: Non Operating Income surged 2104792095.96% in 2024, then plunged 155.44% in 2025.
- A 4-year view of Non Operating Income shows it stood at $629812.0 in 2023, then soared by 2104792095.96% to $13256.2 billion in 2024, then tumbled by 155.44% to -$7349.3 billion in 2025, then jumped by 100.0% to $165268.0 in 2026.
- The last three Non Operating Income figures came in at $165268.0 (Q1 2026), -$7349.3 billion (Q4 2025), and $2545.6 billion (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | -216.00 Mn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 20.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | -7.50 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | -504,111.66 |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 53.40 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | -13.65 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 5.71 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | -23.23 Mn |
| 10 | Grown Rogue International | - | - | 3.96 Mn | 165,268.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 165,268.00 |
| Dec 31, 2025 | -7,349.33 Bn |
| Sep 30, 2025 | 2,545.62 Bn |
| Jun 30, 2025 | 2.54 Mn |
| Mar 31, 2025 | 2.08 Mn |
| Dec 31, 2024 | 13,256.23 Bn |
| Sep 30, 2024 | -1,385.07 Bn |
| Jun 30, 2024 | -7.15 Mn |
| Mar 31, 2024 | -4.72 Mn |
| Dec 31, 2023 | 629,812.00 |
| Apr 30, 2023 | -194,852.00 |
| May 31, 2012 | 237,272.14 |
| Nov 30, 2011 | 246,214.36 |
| May 31, 2011 | 57,588.26 |
| Feb 28, 2011 | -84,234.48 |